Pharming (PHAR) Capital Expenditures (2020 - 2022)
Historic Capital Expenditures for Pharming (PHAR) over the last 5 years, with Q2 2023 value amounting to -$986000.0.
- Pharming's Capital Expenditures fell 8925.14% to -$986000.0 in Q2 2023 from the same period last year, while for Jun 2023 it was -$987071.0, marking a year-over-year increase of 7901.61%. This contributed to the annual value of $800000.0 for FY2024, which is 4432.85% down from last year.
- Pharming's Capital Expenditures amounted to -$986000.0 in Q2 2023, which was down 8925.14% from -$208000.0 recorded in Q4 2022.
- In the past 5 years, Pharming's Capital Expenditures registered a high of $727929.0 during Q3 2022, and its lowest value of -$5.4 million during Q2 2021.
- Over the past 5 years, Pharming's median Capital Expenditures value was -$459657.2 (recorded in 2020), while the average stood at -$1.1 million.
- In the last 5 years, Pharming's Capital Expenditures crashed by 4014879.15% in 2021 and then surged by 13605.5% in 2022.
- Over the past 5 years, Pharming's Capital Expenditures (Quarter) stood at -$2.6 million in 2019, then surged by 99.81% to -$4859.8 in 2020, then crashed by 40148.79% to -$2.0 million in 2021, then skyrocketed by 89.37% to -$208000.0 in 2022, then tumbled by 374.04% to -$986000.0 in 2023.
- Its Capital Expenditures stands at -$986000.0 for Q2 2023, versus -$208000.0 for Q4 2022 and $727929.0 for Q3 2022.